Patent Assignment
Reel/Frame 056483/0440
Assignment of Assignor's Interest
Recorded: 2021-06-09
Pages: 7
Assignors
SEEHRA, JASBIR S.
Executed: 2021-05-07
LACHEY, JENNIFER
Executed: 2021-05-05
FURUTANI, ELISSA
Executed: 2021-05-07
Assignee
KEROS THERAPEUTICS, INC.
99 HAYDEN AVENUE, SUITE 120 (BLDG. E), LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Methods of Using ALK2 Inhibitors
Patent:
12,508,262 →
Application:
17/246,577 →
Publication:
US 2022/0401445
PCT:
PCT/US2021/030362 ↗